SmarterDividends
RDY

Dr. Reddy's Laboratories Limited

RDY

Healthcare · Stock · annual payer

$12.60

Overvalued · -66% Add to Portfolio

Forward Yield

0.66%

Annual Dividend

$0.08

Payout Ratio

16%

5-Yr Growth

6.6%

Ex-Date

Jul 9, 2026

Frequency

Annual

Summary

As of July 2026, Dr. Reddy's Laboratories Limited (RDY) yields 0.66% ($0.08 per share annually), with a blended fair-value estimate of $4.29 — -66% downside, so it screens as overvalued. Dividend safety grade: C (62/100).

Is RDY a good dividend stock?

Yes, with caveats

Dr. Reddy's Laboratories Limited (RDY) pays a annual dividend yielding 0.66% ($0.08/yr), with 0 years of growth and a dividend-safety grade of C. It's a solid income payer, but check the caveats below before buying.

Advantages

  • Comfortable payout ratio (16%)
  • Strong 6.6% 5-yr dividend growth

Risks

  • Cut its dividend in 2025
  • Share price is down over the past 5 years

Key Data

Dividend Yield
0.66%
Payout Ratio
16%
Annual Dividend
$0.08
5-Yr Avg Growth
6.6%
Ex-Dividend Date
Jul 9, 2026
Years of Growth
0
Frequency
annual
Beta
0.26
Market Cap
$10.5B
P/E Ratio
22.9
5-Yr Total Return
-2%
52-Week Range
$12.19 – $15.67
Dividend Safety
C · 62/100
Ever Cut?
Yes (2025)
RDY ex-dividend date & scheduleNext ex-date Jul 9, 2026 · full ex-dividend historyView →

Frequently Asked Questions

Income Calculator

At $0.08 / yr per share

Per payment (annual)$8.00
Annual$8.00
Monthly avg$0.67